The validity and inter-device variability of the Apple Watch™ for measuring maximal heart rate by Abt, Grant. et al.
 1 
The validity and inter-device variability of the Apple Watch™ for measuring maximal 
heart rate 
 
Running title 
Apple Watch maximal heart rate validity and variability 
 
Grant Abt1, James Bray1, Amanda Clare Benson2 
1School of Life Sciences, The University of Hull, U.K;  
2Department of Health and Medical Sciences, Swinburne University of Technology, 
Australia  
 
Correspondence 
Grant Abt Ph.D. 
School of Life Sciences 
The University of Hull 
Kingston upon Hull, HU6 7RX 
United Kingdom 
Email: g.abt@hull.ac.uk 
 
James Bray Ph.D. 
School of Life Sciences 
The University of Hull 
Kingston upon Hull, HU6 7RX 
United Kingdom 
Email: j.bray@hull.ac.uk 
 
Amanda Benson Ph.D. 
Department of Health and Medical Sciences 
 2 
Swinburne University of Technology 
Hawthorn, 3122 
Australia 
Email: abenson@swin.edu.au 
 
Key words 
Intensity, Validity, Reliability, Technology. 
 
Word count 
2418 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Abstract 
Maximal heart rate (HRmax) is a fundamental measure used in exercise prescription. The 
Apple Watch™ measures heart rate yet the validity and inter-device variability of the device 
for measuring HRmax are unknown. Fifteen participants completed a maximal oxygen uptake 
test while wearing an Apple Watch™ on each wrist. Criterion HRmax was measured using a 
Polar T31™ chest strap. There were good to very good correlations between the watches and 
criterion (left: r = 0.87 [90%CI: 0.67 to 0.95]; right: r = 0.98 [90%CI: 0.94 to 0.99]). 
Standardised mean bias for the left and right watches compared to the criterion were 0.14 
(90%CI: -0.12 to 0.39; trivial) and 0.04 (90%CI: -0.07 to 0.15; trivial). Standardised typical 
error of the estimate for the left and right watches compared to the criterion were 0.51 
(90%CI: 0.38 to 0.80; moderate) and 0.22 (90%CI: 0.16 to 0.34; small). Inter-device 
standardised typical error was 0.46 (90%CI: 0.36 to 0.68; moderate), ICC = 0.84 (90%CI: 
0.65 to 0.93). The Apple Watch™ has good to very good criterion validity for measuring 
HRmax, with no substantial under- or over-estimation. There were moderate and small 
prediction errors for the left and right watches. Inter-device variability in HRmax is moderate. 
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Introduction 
Heart rate is often used to prescribe exercise intensity in both the general population and 
athletes. Heart rate reserve (HRR), of which maximal heart rate (HRmax) is a fundamental 
component, is the method recommended for setting the exercise intensity of a training 
session (Achten & Jeukendrup, 2003; Pescatello & American College of Sports Medicine, 
2014). The maximal heart rate included in the HRR method can be obtained by direct 
measurement during a maximal exercise test or predicted using a variety of age-based 
formulae such as the commonly used 220 – age or the more precise 206.9 – (0.67 x age) 
(Gellish et al., 2007) which is now the age-predicted HRmax estimation formula 
recommended by the American College of Sports Medicine (Pescatello & American College 
of Sports Medicine, 2014). Unfortunately, age-based formulas have considerable prediction 
error (Gellish et al., 2007; Robergs & Landwehr, 2002) which means that direct 
measurement of HRmax is still the preferred option if possible.  
 Heart rate can be directly measured by palpation, commonly at the carotid or radial 
pulse, using an ECG (which is not readily accessible to the general public), a telemonitoring 
device, or more recently using photoplethysmography (PPG). Most commercial heart rate 
monitors (e.g. Polar™) detect the electrical signals from the heart, however, during free-
living conditions wearing a chest strap for lengthy periods of time is not always feasible, 
desirable or comfortable. In contrast, PPG measures heart rate using optical sensors that 
detect changes in the volume of blood flow in the capillaries below the skin (Allen, 2007). 
PPG optical sensors shine light through the skin to enable the detection of changes in blood 
volume perfusion of microvascular tissue. These changes are analysed using computer-based 
pulse-wave analysis techniques to determine heart rate (Allen, 2007). The measurement of 
heart rate using an optical sensor placed directly on the skin therefore negates the need for 
the user to wear a chest strap. However, motion artefact, for example that which might be 
observed with movement of the sensor across the skin, can cause measurement error of up to 
8% through ambiguous automated waveform labelling when compared to that of an ECG 
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(Allen, 2007). For quality measurement using PPG, reduced movement of the sensor on the 
skin is imperative (Hertzman, 1938).  
 The consumer ‘wearables’ market, which includes smartwatches, has grown 
considerably over the last few years with forward estimates placing the size of the market at 
over 200 million devices to be sold in 2020 (IDC, 2016). More specifically, the Apple 
Watch™, which includes a PPG sensor for measuring heart rate, is reported to have had sales 
of more than 12 million units in 2015, making it the world’s most popular smartwatch 
(Canalys, 2016). This growth in the wearables market and the popularity of smartwatches 
like the Apple Watch™ have considerable potential for the promotion and monitoring of 
physical activity and exercise. Moreover, monitoring heart rate via a smartwatch enables 
incrementally progressive exercise prescription to maximise health related benefits and the 
provision of instant user feedback to assist with safety, motivation and adherence (Lyons, 
Lewis, Mayrsohn, & Rowland, 2014; Pescatello & American College of Sports Medicine, 
2014). For these reasons, the measurement of heart rate via a smartwatch needs to be both 
valid and reliable. 
 Despite the popularity of the Apple Watch™, there have been a limited number of 
studies examining its validity for measuring heart rate during a variety of submaximal 
activities (Wallen, Gomersall, Keating, Wisløff, & Coombes, 2016; Wang et al., 2016). 
Wallen et al. (2016) compared the validity of four devices for measuring HR (Apple 
Watch™, Fitbit Charge HR™, Samsung Gear S™, Mio ALPHA™), with the Apple 
Watch™ having the lowest mean difference (SD) (-1.3 (4.4) beats.min-1) and limits of 
agreement (-9.9 to 7.3 beats.min-1) compared with an ECG. However, HR was manually 
recorded during the submaximal activities and the process of how HR data were extracted 
from the four devices is not clearly explained. It is also unknown on which arm each of the 
four devices was worn and which two devices were tested together (Wallen et al., 2016). 
Although comparisons were made between the four devices in both studies they were not 
tested simultaneously (Wallen et al., 2016; Wang et al., 2016) and only two of the four 
devices were worn in the study by Wang et al. (2016), which may have caused other 
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unaccounted for measurement error despite randomisation (Wallen et al., 2016; Wang et al., 
2016) and counterbalance allocation (Wallen et al., 2016). Wang et al. (2016) examined the 
validity of the Apple Watch™ HR compared to an ECG and a Polar chest strap. Participants 
exercised on a motorised treadmill at 3.2 km.h-1, 4.8 km.h-1, 6.4 km.h-1, 8 km.h-1, and 9.6 
km.h-1 for 3 min at each stage while wearing two of four wrist-worn devices (Fitbit Charge 
HR™, Apple Watch™, Mio Alpha™, and Basis Peak™). There was a correlation of r = 0.91 
(95%CI: 0.88 to 0.93) between the Apple Watch™ and the ECG. The limits of agreement 
range from -27 to +29 beats.min-1 compared to the ECG. However, HR was only taken once 
manually at the end of each 3-min stage which is a substantial limitation. There was also no 
indication on which wrist the Apple Watch™ was worn.  
 As such, there are substantial limitations with the previous Apple Watch™ studies 
and no study has examined the validity of the Apple Watch™ for measuring HR during 
maximal intensity exercise. Therefore, our aims were to examine the concurrent criterion 
validity of the Apple Watch™ for measuring HRmax, and to examine the variability in HRmax 
between two Apple Watches worn simultaneously on the left and right wrists. 
 
Methods 
Fifteen (8 male, 7 female) recreationally active participants (those meeting the minimum 
ACSM guidelines for physical activity) (mean (SD) age 32 (10) y; body mass 73.5 (14.8) kg; 
stature 175 (8) cm) were enrolled in the study. Following University Human Ethics 
Committee approval (approval number 1516076), participants provided written informed 
consent prior to having their cardiovascular disease risk assessed according to the ACSM 
risk stratification guidelines (Pescatello & American College of Sports Medicine, 2014). All 
participants were stratified as low risk. Participants were recruited from the local community 
and university student body via written promotional material or personal request. Based on 
the data from Wallen et al. (2016) and Wang et al. (2016) who reported correlations of 0.98 
and 0.91 between the Apple Watch and the criterion measure, it is not unreasonable to select 
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0.7 as the smallest correlation worth detecting. Using the formula 32/ES2, a sample of eight 
is derived (Hopkins, 2007). The correlation of 0.7 is considered to be the same as a Cohen’s 
d effect size of 2. 
 A single maximal oxygen uptake test was used to establish the validity and inter-
device variability of the Apple Watch for measuring maximal heart rate. The criterion 
measure of maximal heart rate was considered to be that measured by a Polar T31™ heart 
rate monitor.  
 Nude body mass was measured to the nearest 0.1 kg using digital scales (WB-
100MA Mark 3, Tanita Corporation, Tokyo, Japan). Prior to the measure being taken 
participants were asked if they had voided prior to attending the session. If not, they were 
instructed to do so. Participants were then instructed to remove all clothing. Two 
measurements of body mass were then taken and the mean used for further analysis. Stretch 
stature was measured using a wall-mounted stadiometer (Holtain Ltd, Dyfed, Wales, UK) 
and according to the methods of the International Society for the Advancement of 
Kinanthropometry (Norton et al., 2000).  
 Participants completed a single incremental maximal oxygen uptake test on a 
motorised treadmill (h/p/cosmos, Pulsar, Nussdorf-Traunstein, Germany) while wearing a 
first-generation Apple Watch™ (watchOS 2.0.1) on each wrist (right and left) and a Polar 
T31™ chest strap (Polar, Kempele, Finland). The protocol commenced at 3 km.h-1 at a 1% 
gradient and increased 0.5 km.h-1 in speed every 30 s. Participants continued the protocol 
until volitional fatigue. Oxygen uptake was measured continuously from expired air using an 
online breath-by-breath system (Cortex Metalyzer 3B, GmbH, Germany). The analyser was 
calibrated before each test using room air and known gas concentrations of O2 and CO2. 
Volume was calibrated using a 3 L syringe.  
 Heart rate data were recorded every 5 s on each watch using the ‘Workout’ app. The 
‘Workout’ app automatically syncs exercise data to the ‘Health’ database on its paired 
iPhone after the completion of an exercise session. To retrieve this raw heart rate and 
sampling time data a bespoke iPhone app was used. The bespoke app was written in Xcode 
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7.2.1 using the language Swift 2.1 and utilising the methods provided by the HealthKit 
framework (Apple, Inc). Criterion heart rate were measured using a Polar T31™ chest strap 
interfaced with a metabolic cart. The highest 30 s mean heart rate from each of the three 
devices (Polar T31TM, left Apple Watch, right Apple Watch) were used as the values for 
maximal heart rate. Additionally, age-predicted maximal heart rate were calculated using 
both the 220 - age and 206.9 - [0.67 x age] formulas (Gellish et al., 2007). Although no 
verification phase was conducted, based on established criteria (volitional exhaustion; RER 
> 1.15; plateau in oxygen consumption < 150 mL.min-1) (Howley, Bassett, & Welch, 1995), 
all participants were judged to have reached maximal oxygen consumption and therefore by 
association, HRmax.  
 Data were log transformed prior to analysis to avoid bias resulting from non-
uniformity of error. Differences in the mean heart rate between the criterion and Apple 
Watch™ are reported as Cohen’s d, together with 90% confidence intervals. Apple Watch™ 
validity (N = 14; missing HR data were excluded on one occasion as the Polar T31™ 
monitor did not record heart rate data) is reported as a Pearson correlation (r), standardised 
mean bias, and standardised typical error of the estimate (Hopkins, 2015). The 95% limits of 
agreement were calculated to enable comparison with other studies. Inter-device variability 
(N = 15) is reported as the standardised typical error and intraclass correlation (ICC). 
Uncertainty is reported as a 90% confidence interval. All data were analysed using custom-
designed Microsoft Excel spreadsheets (Hopkins, 2015).  
 
Results 
The mean (SD) maximal heart rate (HRmax) were 183 (12) and 182 (12) beats.min-1 for the 
left and right Apple Watch™, respectively (mean difference -1 beats.min-1 [90%CI: -4 to 2]). 
Mean (SD) HRmax, as measured by the Polar T31™ chest strap (criterion), was 180 (12) 
beats.min-1. There was a good correlation between the left Apple Watch™ and the criterion 
and a very good correlation between the right Apple Watch™ and the criterion (Figure 1). 
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Standardised mean bias for the left and right Apple Watch™ compared to the criterion were 
0.14 (90%CI: -0.12 to 0.39; trivial) and 0.04 (90%CI: -0.07 to 0.15; trivial). Standardised 
typical error of the estimate for the left and right Apple Watch™ compared to the criterion 
were 0.51 (90%CI: 0.38 to 0.80; moderate) and 0.22 (90%CI: 0.16 to 0.34; small). The mean 
bias and 95% limits of agreement were 2 (-10 to 14) and 1 (-4 to 6) for the left and right 
Apple Watches (Figure 2).  
 
INSERT FIGURE 1 ABOUT HERE 
  
INSERT FIGURE 2 ABOUT HERE 
 
Inter-device standardised typical error and ICC are displayed in Figure 3. Individual 
variation in HRmax across the devices compared with age-predicted calculations for HRmax 
are presented in Figure 4. 
 
INSERT FIGURE 3 ABOUT HERE 
 
INSERT FIGURE 4 ABOUT HERE 
 
Discussion 
This is the first time that the validity and inter-device variability of the Apple Watch™ for 
measuring HRmax has been investigated. The Apple Watch™ displayed good to very good 
criterion validity (Hopkins, 2016) for measuring HRmax, an important component of accurate 
exercise prescription, compared to the widely accepted Polar T31™ heart rate monitor. The 
data in our study are largely in agreement with that observed by Wallen et al. (2016) who 
reported the 95% limits of agreement as -10 to 7 beats.min-1. The limits of agreement for the 
left and right Apple Watch™ in our study fall either side of these values, with the left watch 
showing wider limits and the right watch narrower limits. Although the current study has a 
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slightly smaller sample size it is strengthened by the direct access to the raw heart rate data 
and the watches being worn simultaneously during testing, which neither Wallen et al. 
(2016) or Wang et al. (2016) reported doing. Inter-device variability in HRmax measured by 
the Apple Watch™ is moderate when worn simultaneously on different arms. It is unclear 
why one individual had a larger inter-device variability (Figure 3), which warrants further 
investigation as this outlier appears largely responsible for the greater variability in the 
Apple Watch™ worn on the left wrist. Given the error that can be caused by motion artefact 
(Allen, 2007), it is possible that the arm movement of this individual was considerably 
different from other participants, although we have no objective data to confirm or refute this 
assertion.   
 Given the interest in consumer-based sensor and wearable technology (IDC, 2016) it 
is important to have accurate maximal heart rate measurements for exercise prescription, 
especially given the implications for user safety, motivation and adherence. The Apple 
Watch™ was within the range of the typical variability associated with using the 220 - age 
formula (10-12 beats.min-1) and 206.9 - (0.67 x age) formula (5-8 beats.min-1) (Gellish et al., 
2007) and within 3 beats.min-1 of the mean chest strap HRmax demonstrating that using the 
Apple Watch™ is an acceptable alternative method. 
 Unlike measuring HR manually, both the Polar T31™ HR strap and the Apple 
Watch™ enable continuous and immediate feedback of HR during exercise, which has the 
potential to enhance self-regulation, exercise safety and motivation (Lyons et al., 2014). 
Additionally, it could improve the ability to adhere to the exercise prescription. This is 
particularly important when individuals, such as those with chronic diseases, need to stay 
under specific maximal heart rate thresholds recommended by a health professional for 
safety reasons (Price, Gordon, Bird, & Benson, 2016). To that end, mobile health technology 
has been reported to facilitate better management and improved patient confidence in 
monitoring their condition in chronic disease populations (Hamine, Gerth-Guyette, Faulx, 
Green, & Ginsburg, 2015). 
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Conclusions 
The Apple Watch™ has good to very good criterion validity for measuring HRmax, with no 
substantial under- or over-estimation. There were moderate and small prediction errors for 
the left and right watches, respectively. Inter-device variability in HRmax is moderate. Users 
need to weigh up the validity and variability of the device compared with the associated cost 
of the Apple Watch™ or chest strap in determining what is most suitable for their needs. 
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Figure legends 
 
Figure 1. Correlation of maximal heart rate between the Polar™ heart rate strap (criterion) 
and left (A) and right (B) Apple Watch™. 
 
Figure 2. Bland-Altman plots showing the mean bias and 95% limits of agreement for 
maximal heart rate derived from a left (A) and right (B) Apple WatchTM compared to the 
criterion Polar T31TM. 
 
Figure 3. Inter-device (Apple Watch™ worn on the right and left wrist) standardised typical 
error (TE) (A) and intraclass correlation (ICC) (B). 
 
Figure 4. Individual variation in HRmax across the devices (Apple Watch™ worn on left and 
right wrist, Polar™ heart rate strap,) compared with age-predicted calculations. Each black 
bar represents the group mean. 
